[go: up one dir, main page]

AU7211696A - Treatment of chronic progressive renal failure - Google Patents

Treatment of chronic progressive renal failure

Info

Publication number
AU7211696A
AU7211696A AU72116/96A AU7211696A AU7211696A AU 7211696 A AU7211696 A AU 7211696A AU 72116/96 A AU72116/96 A AU 72116/96A AU 7211696 A AU7211696 A AU 7211696A AU 7211696 A AU7211696 A AU 7211696A
Authority
AU
Australia
Prior art keywords
treatment
renal failure
chronic progressive
progressive renal
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72116/96A
Inventor
David Saul Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU7211696A publication Critical patent/AU7211696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU72116/96A 1995-09-27 1996-09-19 Treatment of chronic progressive renal failure Abandoned AU7211696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US449695P 1995-09-27 1995-09-27
US004496 1995-09-27
PCT/EP1996/004101 WO1997011717A1 (en) 1995-09-27 1996-09-19 Treatment of chronic progressive renal failure

Publications (1)

Publication Number Publication Date
AU7211696A true AU7211696A (en) 1997-04-17

Family

ID=21711072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72116/96A Abandoned AU7211696A (en) 1995-09-27 1996-09-19 Treatment of chronic progressive renal failure

Country Status (3)

Country Link
AU (1) AU7211696A (en)
WO (1) WO1997011717A1 (en)
ZA (1) ZA968097B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919343B2 (en) 2002-02-08 2005-07-19 Merck & Co., Inc. N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
CA2473778A1 (en) 2002-02-08 2003-08-14 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238924A (en) * 1984-05-03 1993-08-24 Merck & Co., Inc. Treatment of renal diseases with ace inhibitors
AU569789B2 (en) * 1984-05-03 1988-02-18 Brigham And Women's Hospital A.c.e. inhibitors to treat renal diseases
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
EP0655461B1 (en) * 1993-11-16 2000-06-07 Novartis AG Cyclic amino acid derivatives having ACE and NEP inhibiting activity

Also Published As

Publication number Publication date
ZA968097B (en) 1997-03-27
WO1997011717A1 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
AU6656796A (en) Transcorneal drug-release system
AU2621495A (en) Oil well treatment
AU3815395A (en) Filter
AU7413996A (en) Catheter assembly
EP0737501A3 (en) Strainer
AUPN449295A0 (en) Radioprotectors
AU5351996A (en) Multiple filter unit
AU4757596A (en) Kink-resistant stent-graft
AU2721895A (en) In-line adsorber system
AU7042296A (en) Filters
AU3708795A (en) Prefabricated residence block
AU7314896A (en) Filtering
AU5718396A (en) Wastewater treatment
AU1229495A (en) Suspension type foot massager
AU688690B2 (en) Multi-layer pipe
AU4790296A (en) Filter elements
AU7560296A (en) Medical installation
AU7211696A (en) Treatment of chronic progressive renal failure
AU7427796A (en) Fluid administration
AU2638195A (en) Method of determining renal clearances
AU6076896A (en) Spa sandal
GB9708716D0 (en) Chronic heart failure
AU6071996A (en) Faucet connector assembly
AU7454396A (en) Heparin chromatography of erythropoietins
AU5809396A (en) Multi-layer insole